Inflation Reduction Act Weakens Drug Development

Americans today are benefiting from significant innovation across multiple therapeutic areas. We are on the cusp of highly effective treatments in obesity and important progress is being made in the fight against notoriously challenging diseases like Alzheimer's. The state of drug development in America is strong. But we cannot take it for granted and we must protect it against short-sighted policies not in the best interest of patients.

 

Read Full Article »
Comment
Show comments Hide Comments

Related Articles